FDA Grants AP Status for Methotrexate Sodium ANDA216453
The FDA has granted approval status (AP) for the ANDA216453 application for Methotrexate Sodium submitted by Elite Labs Inc.
Company
Pharmaceutical intelligence for Elite Labs Inc. with 2 indexed intelligence signals across regulatory, clinical, competitive, and market developments.
No catalysts indexed for this entity yet.
No signals indexed for this entity yet.
No signals indexed for this entity yet.
No related entities indexed yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.